Radiodermatitis Market cover

Radiodermatitis Market by Products (Topical [Antibiotics, Hydrophilic Creams, Corticosteroids, and Others], Oral, and Dressings [No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressings, Hydrogel & Hydrocolloid Dressings, and Others]), Distribution Channels (Retail Pharmacy, Hospital Pharmacy, and Online), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2298
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 193
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global radiodermatitis market size is estimated to register a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the growing number of patients suffering from skin cancer and rising demand for the cancer treatment.

Radiodermatitis Market summary

Radiodermatitis, also known as radiation-induced skin reactions, is a type of skin cancer that has occurred as a side effect of ionizing radiation to the skin due to exposing to radiation. This is mainly caused due to some disasters such as nuclear radiation. The market is significantly boosted due to the rising number of cancer patients who are experiencing a cutaneous reaction as a result of radiation therapy or radiotherapy during cancer treatment. This led to rising need for clinical emergency to cure this side effect, driving demand for urgent requirement for the effective treatment products and methods. A significant acceptance of radiodermatitis products to improve quality of life presents a key insight of the market. This is expected to result in positive influence on the market.

The growing number of healthcare initiatives from both private & public authorities is continuously striving to foster awareness on the cancer treatment. Additionally, these organizations circulate guidelines and recommendations to treat the condition efficiently. For instance, Provincial Health Services Authority circulated guidelines on radiodermatitis symptom management and information consisting of the disorder risk elements. This is projected to promote awareness with respect to treatment procedures and general skincare suggestions.

Market Trends, Drivers, Restraints, and Opportunities

  • Wide number of patients suffering from radiodermatitis and skin cancer is expected to accelerate the market growth.
  • Rapid adoption of radiotherapy for the cancer treatment is expected to drive the market growth at a rapid pace in the coming years.
  • Rising government participation and introduction of public healthcare policies to spread awareness of several types of cancer are key drivers of the market.
  • Expansion of clinical studies and wide research activities for improving the development of radiodermatitis treatment methods are expected to present several significant growth opportunities of the market. 
  • Availability of a wide range of innovative cancer treatment products to meet the needs for different requirements of patients are expected to boost the future growth of the market.
  • High cost of radiotherapy and issues concerning the lack of prolonged improvement of cancer patients are key challenges that can hamper the market growth.

Scope of the Report                         

The report on the global radiodermatitis market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Radiodermatitis  Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Years

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Topical [Antibiotics, Hydrophilic Creams, Corticosteroids, and Others], Oral, and Dressings [No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressings, Hydrogel & Hydrocolloid Dressings, and Others]), and Distribution Channels (Retail Pharmacy, Hospital Pharmacy, and Online)

Regional Scopes

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

ICON Plc.; Charles River Laboratory; ICON Plc.; Taconic Biosciences; Covance; EVOTEC SE; Eurofins Scientific; The Jackson Laboratory; MI Bioresearch, Inc.; Living Tumor Laboratory; Wuxi AppTec Champion Oncology, Inc.; XenTech; and Crown Bioscience International

Market Segment Insights

Dressings segment is expected to grow at a rapid pace

Based on products, the global radiodermatitis market is divided into topical, oral, and dressings. The topical segment is further segmented into antibiotics, hydrophilic creams, corticosteroids, and others. The dressings segment is sub-divided into no sting barrier film, honey impregnated gauze, silicone coated dressings, hydrogel & hydrocolloid dressings, and others. The dressings segment is anticipated to expand at a rapid pace during the projected period owing to wide range of products in the market. However, the topical segment is expected to account for a key share of the market during the forecast period due to gold standard in the treatment of inflammatory skin conditions.

Radiodermatitis Market product

Retail pharmacy segment is projected to expand at a considerable CAGR

On the basis of distribution channels, the market is segregated into retail pharmacy, hospital pharmacy, and online. The retail pharmacy segment is projected to expand at a considerable CAGR during the forecast period owing to high accessibility and affordability linked with retail stores. Meanwhile, the online segment is anticipated to hold a large market share during the forecast period due to various advantages such as increased convenience for patients.

Asia Pacific is anticipated to constitute a major market share

In terms of regions, the global radiodermatitis market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of Asia Pacific accounted for a key share of the market in 2019 and is anticipated to constitute a major market share in the coming years owing to expanding cancer patient base present in the region. The market of North America, however, is expected to exhibit a high growth rate during the targeted period due to high investment on research and development activities in the region.

Radiodermatitis Market region

Segments

Segments Covered in the Report

The global radiodermatitis market has been segmented on the basis of

Products

  • Topical
    • Antibiotics
    • Hydrophilic Creams
    • Corticosteroids
    • Others
  • Oral
  • Dressings
    • No Sting Barrier Film
    • Honey Impregnated Gauze
    • Silicone Coated Dressings
    • Hydrogel & Hydrocolloid Dressings
    • Others

Distribution Channels

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • ICON Plc.
  • Charles River Laboratory
  • Taconic Biosciences
  • Covance
  • EVOTEC SE
  • Eurofins Scientific
  • The Jackson Laboratory
  • MI Bioresearch, Inc.
  • Living Tumor Laboratory
  • Wuxi AppTec Champion Oncology, Inc.
  • XenTech
  • Crown Bioscience International.

Competitive Landscape

Key players competing in the global radiodermatitis market are ICON Plc.; Charles River Laboratory; Taconic Biosciences; Covance; EVOTEC SE; Eurofins Scientific; The Jackson Laboratory; MI Bioresearch, Inc.; Living Tumor Laboratory; Wuxi AppTec Champion Oncology, Inc.; XenTech; and Crown Bioscience International. These main market players are continuously engaged in wide range of business development activities such as mergers, acquisitions, research and developments, investments for innovative products, and collaborations to enhance their market positions. For instance, ConvaTec introduced new sizes for its product, AQUACEL Foam dressings in May 2016.

Radiodermatitis Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Radiodermatitis Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Radiodermatitis Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Radiodermatitis Market - Supply Chain
  4.5. Global Radiodermatitis Market Forecast
     4.5.1. Radiodermatitis Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Radiodermatitis Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Radiodermatitis Market Absolute $ Opportunity
5. Global Radiodermatitis Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Radiodermatitis Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Radiodermatitis Demand Share Forecast, 2019-2026
6. North America Radiodermatitis Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Radiodermatitis Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Radiodermatitis Demand Share Forecast, 2019-2026
7. Latin America Radiodermatitis Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Radiodermatitis Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Radiodermatitis Demand Share Forecast, 2019-2026
8. Europe Radiodermatitis Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Radiodermatitis Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Radiodermatitis Demand Share Forecast, 2019-2026
9. Asia Pacific Radiodermatitis Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Radiodermatitis Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Radiodermatitis Demand Share Forecast, 2019-2026
10. Middle East & Africa Radiodermatitis Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Radiodermatitis Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Radiodermatitis Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Radiodermatitis Market: Market Share Analysis
  11.2. Radiodermatitis Distributors and Customers
  11.3. Radiodermatitis Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. ICON Plc.
     11.4.2. Charles River Laboratory
     11.4.3. Taconic Biosciences
     11.4.4. Covance
     11.4.5. EVOTEC SE
     11.4.6. Eurofins Scientific
     11.4.7. The Jackson Laboratory
     11.4.8. MI Bioresearch, In

Segments Covered in the Report

The global radiodermatitis market has been segmented on the basis of

Products

  • Topical
    • Antibiotics
    • Hydrophilic Creams
    • Corticosteroids
    • Others
  • Oral
  • Dressings
    • No Sting Barrier Film
    • Honey Impregnated Gauze
    • Silicone Coated Dressings
    • Hydrogel & Hydrocolloid Dressings
    • Others

Distribution Channels

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • ICON Plc.
  • Charles River Laboratory
  • Taconic Biosciences
  • Covance
  • EVOTEC SE
  • Eurofins Scientific
  • The Jackson Laboratory
  • MI Bioresearch, Inc.
  • Living Tumor Laboratory
  • Wuxi AppTec Champion Oncology, Inc.
  • XenTech
  • Crown Bioscience International.

Key players competing in the global radiodermatitis market are ICON Plc.; Charles River Laboratory; Taconic Biosciences; Covance; EVOTEC SE; Eurofins Scientific; The Jackson Laboratory; MI Bioresearch, Inc.; Living Tumor Laboratory; Wuxi AppTec Champion Oncology, Inc.; XenTech; and Crown Bioscience International. These main market players are continuously engaged in wide range of business development activities such as mergers, acquisitions, research and developments, investments for innovative products, and collaborations to enhance their market positions. For instance, ConvaTec introduced new sizes for its product, AQUACEL Foam dressings in May 2016.

Radiodermatitis Market keyplayers

Buy Report